Laxans

Bisacodyl, the active ingredient in Laxans, is a stimulant laxative presented as an unknown/unknown for oral use. It treats constipation in adults and children by stimulating bowel movements.

GNH USA supplies Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl is a stimulant laxative that acts on the colon to relieve various forms of constipation. - Constipation: provides relief by stimulating colonic peristalsis and facilitating stool passage. - Opioid‑induced constipation: helps restore bowel function in patients receiving opioid therapy. - Bowel preparation: used occasionally to clear the intestine before diagnostic procedures.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps or pain - Diarrhea or loose stools - Nausea or mild vomiting - Increased thirst - Flatulence or gas buildup - Rectal irritation or mild burning

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., low potassium) - Marked dehydration - Allergic reactions such as rash or swelling - Acute colitis or severe abdominal inflammation - Rectal bleeding or ulceration

Bisacodyl should be used with care, especially in patients with underlying health conditions. - Assess hydration status: ensure adequate fluid intake before and during use. - Use only as directed: follow prescriber or label instructions for duration and dose. - Avoid prolonged use: long‑term therapy may lead to dependence or electrolyte disturbances. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Monitor electrolyte balance: especially in elderly or patients on diuretics. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Bisacodyl can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative effect. - Loop diuretics: increase risk of electrolyte disturbances. - Cardiac glycosides (e.g., digoxin): heightened risk of arrhythmia due to potassium loss.

Moderate Interactions (Monitor Closely): - NSAIDs: additive gastrointestinal irritation. - Calcium or iron supplements: may diminish bisacodyl absorption and effectiveness.